Columbia's Herbert Irving Comprehensive Cancer Center in Upper Manhattan has held NCI designation since 1972; its scientists defined the genetic lesions of B-cell lymphoma, discovered and named ferroptosis in 2012, and spun out the systems biology company DarwinHealth, while Dawn Hershman leads SWOG's cancer care delivery research.
NCI-designated since 1972, the Herbert Irving Comprehensive Cancer Center is the cancer centre of Columbia University Irving Medical Center and NewYork-Presbyterian in Upper Manhattan. Riccardo Dalla-Favera defined BCL6 and the genetic lesions of B-cell lymphoma; Andrea Califano's systems biology of master regulators spun out DarwinHealth; Brent Stockwell discovered and named ferroptosis in 2012; Adolfo Ferrando dissected T-cell acute lymphoblastic leukaemia. Dawn Hershman leads SWOG's cancer care delivery research from here, and Siddhartha Mukherjee, author of The Emperor of All Maladies, runs a leukaemia laboratory. Director Anil Rustgi is a GI cancer biologist.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-01.
Matched to Columbia University, including child institutions. 1,218 works · 17,201 citations · 70% open access · 7% clinical trials · 2% reviews.
New York neuro-oncologist who led INTELLANCE-1, the trial that tested the EGFR-directed antibody-drug conjugate depatuxizumab mafodotin in newly diagnosed glioblastoma and found it did not extend survival.
Herbert and Florence Irving's gifts to Columbia began with $8.5 million in 1987, founded its cancer centre in 1995 and ended with a $700 million bequest in 2017 for cancer research; the total passed $900 million.
Designed the second-generation CAR with a CD28 costimulatory domain that made CAR-T therapy work.
Breast oncologist who co-leads SWOG and studies adherence, toxicity, and how care is actually delivered.
Shares SWOG Cancer Research Network, National Cancer Institute (NIH), Prostate cancer.
Shares SWOG Cancer Research Network, HR-positive / HER2-negative breast cancer.
Shares SWOG Cancer Research Network, HR-positive / HER2-negative breast cancer.
Shares SWOG Cancer Research Network, National Cancer Institute (NIH).
Shares Tumour heterogeneity and clonal evolution, National Cancer Institute (NIH), Diffuse large B-cell lymphoma.
Shares SWOG Cancer Research Network, National Cancer Institute (NIH).
Shares SWOG Cancer Research Network, Diffuse large B-cell lymphoma.
Open-source projects that this organisation maintains, from OnCo's own catalogue: licence and last activity as the repository reported them on the day of the fetch. Listing is not endorsement; check the licence before reuse and the validation before clinical use.
A trainable, open reproduction of AlphaFold 2 from the AlQuraishi lab, with training data released.